Mar 25, 2020 / 01:00PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Silence Therapeutics Webcast and Conference Call.
(Operator Instructions) As a reminder, today's conference is being recorded. I would now like to turn the call over to Mr. Iain Ross, Executive Chairman. Please go ahead, sir.
Iain Gladstone Ross - Silence Therapeutics plc - Executive Chairman
Hi, good afternoon. We live an extraordinary time for the moment, and I hope everyone is well and safe. For us, at Silence, it's an extraordinary day because we think we've actually done an extraordinary deal and to manage to get this concluded over the last couple of weeks has been quite a challenge. What I'd like to do is basically introduce our speakers this afternoon. What I'm going to ask is for John Strafford, who's our Head of Business Development, to talk you through the collaboration that we've put together with AstraZeneca. And also for Rob Quinn, our Chief Financial Officer, to go through the numbers and give you some more detail. Then we'll move through to Giles Campion, who's going to give you an
Silence Therapeutics PLC Collaboration With AstraZeneca and R&D Update Call Transcript
Mar 25, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers